Blood pressure response to exposure to moderate altitude in patients with COPD.


Journal

International journal of chronic obstructive pulmonary disease
ISSN: 1178-2005
Titre abrégé: Int J Chron Obstruct Pulmon Dis
Pays: New Zealand
ID NLM: 101273481

Informations de publication

Date de publication:
2019
Historique:
entrez: 3 4 2019
pubmed: 3 4 2019
medline: 20 12 2019
Statut: epublish

Résumé

Patients with COPD might be particularly susceptible to hypoxia-induced autonomic dysregulation. Decreased baroreflex sensitivity (BRS) and increased blood pressure (BP) variability (BPV) are markers of impaired cardiovascular autonomic regulation and there is evidence for an association between decreased BRS/increased BPV and high cardiovascular risk. The aim of this study was to evaluate the effect of short-term exposure to moderate altitude on BP and measures of cardiovascular autonomic regulation in COPD patients. Continuous morning beat-to-beat BP was noninvasively measured with a Finometer Thirty-seven patients with moderate to severe COPD (mean±SD age 64±6 years, FEV Exposure of COPD patients to moderate altitude is associated with a clinically relevant increase in BP, which seems to be related to autonomic dysregulation. ClinicalTrials.gov (NCT01875133).

Identifiants

pubmed: 30936690
doi: 10.2147/COPD.S194426
pii: copd-14-659
pmc: PMC6421900
doi:

Banques de données

ClinicalTrials.gov
['NCT01875133']

Types de publication

Comparative Study Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

659-666

Déclaration de conflit d'intérêts

Disclosure The authors declare no conflict of interest in this work.

Références

Chest. 2000 Sep;118(3):691-6
pubmed: 10988190
PLoS One. 2013 Aug 01;8(8):e70081
pubmed: 23936377
J R Army Med Corps. 2011 Mar;157(1):110-3
pubmed: 21465920
Clin Auton Res. 1999 Jun;9(3):123-7
pubmed: 10454057
J Aerosol Med Pulm Drug Deliv. 2015 Apr;28(2):100-5
pubmed: 24840562
Thorax. 1982 Apr;37(4):292-5
pubmed: 7112459
Am J Hypertens. 2013 Oct;26(10):1210-7
pubmed: 23744496
Eur Respir J. 2008 Sep;32(3):637-43
pubmed: 18550610
Aviat Space Environ Med. 2002 Jul;73(7):632-4
pubmed: 12137097
Cardiovasc Res. 1998 Jun;38(3):605-16
pubmed: 9747429
J Appl Physiol (1985). 1999 Dec;87(6):2053-8
pubmed: 10601149
Stroke. 2014 Feb;45(2):533-8
pubmed: 24407950
Acta Physiol Scand. 2001 Dec;173(4):409-17
pubmed: 11903133
Hypertension. 2014 Nov;64(5):943-50
pubmed: 25156170
Respiration. 2018;95(6):422-432
pubmed: 29502125
PLoS One. 2014 Jan 03;9(1):e84274
pubmed: 24404157
Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65
pubmed: 22878278
Clin Sci (Lond). 1980 Dec;59 Suppl 6:401s-404s
pubmed: 7449290
Am J Med. 1993 Apr;94(4):407-12
pubmed: 8475934
Curr Hypertens Rep. 2012 Oct;14(5):421-31
pubmed: 22903810
J Hypertens. 2008 Jul;26(7):1373-8
pubmed: 18551013
Lancet. 2010 Mar 13;375(9718):895-905
pubmed: 20226988
Am J Respir Crit Care Med. 2001 Aug 15;164(4):597-601
pubmed: 11520722
Circulation. 1996 Mar 1;93(5):1043-65
pubmed: 8598068
Discov Med. 2012 Dec;14(79):359-68
pubmed: 23272688
JAMA. 1978 Sep 29;240(14):1491-4
pubmed: 682352
Sleep. 2019 Jan 1;42(1):
pubmed: 30517695
Ann N Y Acad Sci. 2001 Jun;940:324-37
pubmed: 11458690
Blood Press Monit. 2015 Jun;20(3):113-20
pubmed: 25943466
J Hypertens Suppl. 1995 Dec;13(4):S27-34
pubmed: 8824684
Sleep. 2013 Dec 01;36(12):1969-76
pubmed: 24293773
Hypertension. 2001 Mar;37(3):911-6
pubmed: 11244017
J Hypertens. 1987 Feb;5(1):93-8
pubmed: 3584967
Lancet Respir Med. 2015 Aug;3(8):631-9
pubmed: 26208998
Lancet. 1998 Feb 14;351(9101):478-84
pubmed: 9482439
Hippokratia. 2008 Aug;12 Suppl 1:84-90
pubmed: 19048098
Metabolism. 1994 Oct;43(10):1226-32
pubmed: 7934973
Respiration. 2019;97(2):125-134
pubmed: 30269143
Am J Respir Crit Care Med. 2018 Jul 1;198(1):51-57
pubmed: 29442524

Auteurs

Esther I Schwarz (EI)

Department of Pulmonology and Sleep Disorders Centre, University Hospital of Zurich, Zurich, Switzerland, malcolm.kohler@usz.ch.

Tsogyal D Latshang (TD)

Department of Pulmonology and Sleep Disorders Centre, University Hospital of Zurich, Zurich, Switzerland, malcolm.kohler@usz.ch.

Michael Furian (M)

Department of Pulmonology and Sleep Disorders Centre, University Hospital of Zurich, Zurich, Switzerland, malcolm.kohler@usz.ch.

Deborah Flück (D)

Department of Pulmonology and Sleep Disorders Centre, University Hospital of Zurich, Zurich, Switzerland, malcolm.kohler@usz.ch.

Sebastian Segitz (S)

Department of Pulmonology and Sleep Disorders Centre, University Hospital of Zurich, Zurich, Switzerland, malcolm.kohler@usz.ch.

Severine Müller-Mottet (S)

Department of Pulmonology and Sleep Disorders Centre, University Hospital of Zurich, Zurich, Switzerland, malcolm.kohler@usz.ch.

Silvia Ulrich (S)

Department of Pulmonology and Sleep Disorders Centre, University Hospital of Zurich, Zurich, Switzerland, malcolm.kohler@usz.ch.

Konrad E Bloch (KE)

Department of Pulmonology and Sleep Disorders Centre, University Hospital of Zurich, Zurich, Switzerland, malcolm.kohler@usz.ch.
Centre for Integrative Human Physiology, University of Zurich, Zurich, Switzerland, malcolm.kohler@usz.ch.

Malcolm Kohler (M)

Department of Pulmonology and Sleep Disorders Centre, University Hospital of Zurich, Zurich, Switzerland, malcolm.kohler@usz.ch.
Centre for Integrative Human Physiology, University of Zurich, Zurich, Switzerland, malcolm.kohler@usz.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH